Co-Authors
This is a "connection" page, showing publications co-authored by Kamal Shah and Ketty Peris.
Connection Strength
0.045
-
Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for =156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2). J Am Acad Dermatol. 2017 Aug; 77(2):310-317.e1.
Score: 0.045
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.